Tony DiMeo
Head of Investor Relations
Replay available
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Q4 2025 earnings conference call, held 2026-02-27. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Co-Founder & Co-CEO
Co-Founder & Co-CEO
Chief Financial Officer
Analyst, J.P. Morgan
Analyst, Goldman Sachs
Analyst, Piper Sandler
Analyst, Tortoise Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Amneal Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.182 Thank you all for your patience. The conference call titled Amneal Pharmaceuticals Fourth 00:00:05.182 -- 00:00:08.910 Quarter and Full Year 2025 Earnings Call will begin shortly. 00:00:08.910 -- 00:00:14.281 During the presentation, you'll have the opportunity to ask a question by pressing star 00:00:14.281 -- 00:00:17.648 followed by the number one on your telephone keypads. 00:00:17.648 -- 00:00:22.133 Again, please stand by and we will begin in a few minutes. 00:00:23.453 -- 00:00:25.453 Thank 00:00:33.788 -- 00:00:35.788 you. 00:01:18.112 -- 00:01:20.112 Thank 00:01:21.021 -- 00:01:23.021 you. 00:01:41.939 -- 00:01:46.585 Good morning, and welcome to the Amniel Pharmaceuticals fourth quarter and full year 00:01:46.585 -- 00:01:51.691 2025 earnings call. I'll now hand the call over to Amniel's head 00:01:51.691 -- 00:01:56.774 of investor relations, Tony DiMeo. Go ahead, please, sir. 00:01:57.558 -- 00:02:02.624 Good morning, and thank you for joining Amniel Pharmaceuticals fourth quarter 2025 earnings 00:02:02.624 -- 00:02:07.309 call. Today, we issued a press release reporting Q4 results. 00:02:07.309 -- 00:02:12.078 The earnings press release and presentation are available at amniel.com. 00:02:12.078 -- 00:02:16.965 Certain statements made on this call regarding matters that are not historical flags, 00:02:16.965 -- 00:02:21.871 including but not limited to management's outlook or predictions, are forward-looking 00:02:21.871 -- 00:02:27.957 statements that are based solely on information that is now available to us. 00:02:28.040 -- 00:02:32.406 Please see the section entitled Cautionary Statements on Forward-Looking Statements for 00:02:32.406 -- 00:02:35.530 factors that may impact future performance. 00:02:35.530 -- 00:02...